Omnia SanaPlant Comparison
Blessed Thistle vs Eyebright
A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.
At a glance
Blessed Thistle and Eyebright: they share 6 indicated uses (arthritis / joint pain, cancer (anticancer research), infection (general), …); 2 pharmacological actions in common.
Evidence face-off — shared uses
| Condition | Blessed Thistle | Eyebright | Verdict |
|---|---|---|---|
| Arthritis / joint pain | 1/10 | 1/10 | Comparable evidence |
| Cancer (anticancer research) | 2/10 | 2/10 | Comparable evidence |
| Infection (general) | 1/10 | 2/10 | Comparable evidence |
| Inflammation (general) | 1/10 | 2/10 | Comparable evidence |
| Skin irritation | 1/10 | 1/10 | Comparable evidence |
| Wounds | 1/10 | 1/10 | Comparable evidence |
Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.
Key Constituents
Give the plant its anti-inflammatory action on irritated tissue.
Pharmacological Actions
Appetite stimulant for loss of appetite (approved use under German Commission E)
Bitter digestive / stomachic for indigestion and dyspepsia (stimulates saliva and gastric secretion)
Bitter digestive / stomachic for indigestion and dyspepsia (stimulates saliva and gastric secretion)
Astringent and anti-inflammatory for eye irritation, redness and conjunctivitis (traditional, as an eye compress or bath) - an open prospective cohort of Euphrasia single-dose eye drops reported recovery or clear improvement in most patients with conjunctivitis
Traditional & Indicated Uses
Appetite stimulant for loss of appetite (approved use under German Commission E)
inferred from anti-inflammatory action
inferred from anticancer action
Bitter digestive / stomachic for indigestion and dyspepsia (stimulates saliva and gastric secretion)
inferred from antimicrobial action
inferred from anti-inflammatory action
Galactagogue to support breast-milk supply (traditional; no valid clinical-trial evidence)
inferred from anti-inflammatory action
Eases eye strain and watery, itchy eyes from allergy (hay fever / allergic conjunctivitis)
inferred from anti-inflammatory action
inferred from anticancer action
Soothes upper-respiratory catarrh and mild infection (traditional)
Astringent and anti-inflammatory for eye irritation, redness and conjunctivitis (traditional, as an eye compress or bath) - an open prospective cohort of Euphrasia single-dose eye drops reported recovery or clear improvement in most patients with conjunctivitis; Eases eye strain and watery, itchy eyes from allergy (hay fever / allergic conjunctivitis)
Eases eye strain and watery, itchy eyes from allergy (hay fever / allergic conjunctivitis)
Soothes upper-respiratory catarrh and mild infection (traditional)
inferred from anti-inflammatory action
Soothes upper-respiratory catarrh and mild infection (traditional)
inferred from anti-inflammatory action
Safety, Cautions & Contraindications
As a member of the daisy family (Asteraceae/ragweed), it can cause allergic reactions in sensitive people; high doses reportedly cause stomach cramps, nausea and vomiting.
Avoid during pregnancy because of a traditional uterine-stimulating reputation.
Although traditionally used to support milk supply, there is no scientifically valid clinical evidence for the galactagogue use.
CRITICAL: do not put non-sterile, homemade eyebright preparations directly into the eye - this risks serious eye infection. Use only commercially prepared sterile products in the eye, or apply a strained, cooled infusion as a compress over closed eyelids.
Traditional use only; persistent eye symptoms, pain, discharge or vision change need assessment by an eye-care professional. Safety in pregnancy and breastfeeding is not established.
External Ids
Botanical Description
Branching annual herb with a hairy, reddish, ridged stem and spiny, deeply lobed leaves with prominent pale veins. The flower heads are pale yellow, thistle-like, surrounded by a whorl of spiny, leaf-like bracts, giving the plant its 'spotted thistle' appearance.[4]
Small, semi-parasitic annual herb (drawing some nutrients from the roots of neighbouring grasses) with tiny, opposite, toothed leaves and delicate, two-lipped white to pale lilac flowers marked with purple veins and a yellow throat spot, giving a bright, eye-like appearance that inspired both its common and Latin names.[11]
Habitat
Grows on dry, sunny waste ground, roadsides and rocky slopes; native to the Mediterranean region and Western Asia and naturalised elsewhere as a garden escape.[4]
Grows in short, unimproved grassland, pastures, meadows and dunes on well-drained soils, always in association with grasses on which it partially parasitises; native to Europe.[11]
Harvesting
The flowering aerial parts are cut as the plant comes into flower, in summer, and dried in a warm, shaded, airy place to preserve the bitter principle cnicin.[4]
The flowering aerial parts are cut in summer while in flower and dried in a warm, shaded, airy place.[11]
Traditional Uses
Blessed thistle has a long European folk reputation as a bitter digestive tonic for loss of appetite and dyspepsia (an approved use under German Commission E) and, more anecdotally, as a traditional galactagogue to support breast-milk supply, though robust clinical evidence for the latter is lacking.[4, 11]
Preparations
Dried flowering herb infused briefly in hot water as a bitter digestive tea, taken before meals.
Strained, cooled infusion applied as a compress over closed eyelids, or used (only when sterile, commercially prepared) as an eyewash for irritated or red eyes.
Commercially prepared, sterile Euphrasia eye drops used for conjunctivitis; a prospective clinical cohort found improvement in most users.
Dosage
Traditional herbal references suggest around 1-2 g of dried herb per cup, taken before meals, up to three times daily. Educational reference only, not a prescription.
No dose is given here because no official posology exists. The HMPC assessed eyebright and DECLINED to establish a herbal monograph, concluding that the efficacy of the claimed uses is undocumented and that external eye application of ex tempore (home-prepared) preparations is 'not hygienic and not safe', so therapeutic use cannot be recommended. Traditional sources describe a strained, cooled infusion used as a compress, but that is precisely the practice the HMPC advised against; nothing home-prepared should be put in or on the eye. Educational reference only, not a prescription.
References
Lookalikes Review
References & Sources
- Rezig, K., Benkaci-Ali, F., Foucaunier, M.L., Laurent, S. et al (2023) 'HPLC/ESI-MS Characterization of Phenolic Compounds from Cnicus benedictus L. Roots: A Study of Antioxidant, Antibacterial, Anti-Inflammatory, and Anti-Alzheimer's Activity', Chemistry & Biodiversity, 21(1), pp. e202300724. doi:10.1002/cbdv.202300724 Preclinical
https://doi.org/10.1002/cbdv.202300724 - Ahmadimoghaddam, D., Sadeghian, R., Ranjbar, A., Izadidastenaei, Z. and Mohammadi, S (2020) 'Antinociceptive activity of Cnicus benedictus L. leaf extract: a mechanistic evaluation', Research in Pharmaceutical Sciences, 15(5), pp. 463-472. doi:10.4103/1735-5362.297849 Preclinical
https://doi.org/10.4103/1735-5362.297849 - Zhang, J., Shen, S., Zhu, S., Jia, F. et al (2024) 'Cnicus benedictus extract-loaded electrospun gelatin wound dressing for treating diabetic wounds: An in vitro and in vivo study', Journal of Applied Biomaterials & Functional Materials, 22, pp. 22808000241245298. doi:10.1177/22808000241245298 Preclinical
https://doi.org/10.1177/22808000241245298 - Zietal, K., Mirowska-Guzel, D., Nowaczyk, A. and Blecharz-Klin, K (2024) 'Cnicus benedictus: Folk Medicinal Uses, Biological Activities, and In Silico Screening of Main Phytochemical Constituents', Planta Medica. doi:10.1055/a-2401-6049 Traditional / reference
https://doi.org/10.1055/a-2401-6049 - Jalil, D.M., Al-Mahdawi, T.T., Jameel, M.G. and Talal, M (2024) 'In Vitro Evaluate the Antiproliferative Impact of Cnicus Benedictus L. Leaves Methanolic Extract on Cervical Cancer', Asian Pacific Journal of Cancer Prevention, 25(10), pp. 3643-3649. doi:10.31557/APJCP.2024.25.10.3643 Preclinical
https://doi.org/10.31557/APJCP.2024.25.10.3643 - Peng, Y., Jian, Y., Zulfiqar, A., Li, B., Zhang, K., Long, F., Peng, C., Cai, X., Khan, I.A. and Wang, W (2017) 'Two new sesquiterpene lactone glycosides from Cnicus benedictus', Natural Product Research, 31(19), pp. 2211-2217. doi:10.1080/14786419.2017.1295239 Preclinical
https://doi.org/10.1080/14786419.2017.1295239 - Paun, G., Neagu, E., Moroeanu, V., Albu, C., Savin, S. and Lucian Radu, G (2019) 'Chemical and Bioactivity Evaluation of Cnicus benedictus and Eryngium planum Polyphenolic-Rich Extracts', BioMed Research International, 2019, pp. 3692605. doi:10.1155/2019/3692605 Preclinical
https://doi.org/10.1155/2019/3692605 - Gobrecht, P., Gebel, J., Leibinger, M., Zeitler, C., Chen, Z., Grundemann, D. and Fischer, D (2024) 'Cnicin promotes functional nerve regeneration', Phytomedicine, 129, pp. 155641. doi:10.1016/j.phymed.2024.155641 Preclinical
https://doi.org/10.1016/j.phymed.2024.155641 - Avula, B., Katragunta, K., Wang, Y.H., Ali, Z. and Khan, I.A (2022) 'Simultaneous determination and characterization of flavonoids, sesquiterpene lactone, and other phenolics from Centaurea benedicta and dietary supplements using UHPLC-PDA-MS and LC-DAD-QToF', Journal of Pharmaceutical and Biomedical Analysis, 216, pp. 114806. doi:10.1016/j.jpba.2022.114806 Preclinical
https://doi.org/10.1016/j.jpba.2022.114806 - Paun, G., Neagu, E., Albu, C. and Radu, G.L (2015) 'Inhibitory potential of some Romanian medicinal plants against enzymes linked to neurodegenerative diseases and their antioxidant activity', Pharmacognosy Magazine, 11(Suppl 1), pp. S110-S116. doi:10.4103/0973-1296.157709 Preclinical
https://doi.org/10.4103/0973-1296.157709 - Drugs.com (n.d.) 'Blessed Thistle Uses, Benefits & Dosage'. Available at: https://www.drugs.com/npp/blessed-thistle.html Traditional / reference
https://www.drugs.com/npp/blessed-thistle.html - Drugs and Lactation Database (LactMed) (2021) 'Blessed Thistle'. Available at: https://www.ncbi.nlm.nih.gov/books/NBK501775/ Traditional / reference
https://www.ncbi.nlm.nih.gov/books/NBK501775/
- Novy, P., Davidova, H., Serrano-Rojero, C.S., Rondevaldova, J. et al (2015) 'Composition and Antimicrobial Activity of Euphrasia rostkoviana Hayne Essential Oil', Evidence-Based Complementary and Alternative Medicine, 2015, pp. 734101. doi:10.1155/2015/734101 Preclinical
https://doi.org/10.1155/2015/734101 - D'Ambrosio, M., Ciocarlan, A. and Aricu, A (2020) 'Minor acetylated metabolites from Euphrasia rostkoviana', Natural Product Research, 34(2), pp. 290-295. doi:10.1080/14786419.2018.1530227 Preclinical
https://doi.org/10.1080/14786419.2018.1530227 - Ververis, A., Kyriakou, S., Paraskeva, H., Panayiotidis, M.I. et al (2024) 'Chemical Characterization and Assessment of the Neuroprotective Potential of Euphrasia officinalis', International Journal of Molecular Sciences, 25(23), pp. 12902. doi:10.3390/ijms252312902 Preclinical
https://doi.org/10.3390/ijms252312902 - Meier-Girard, D., Gerstenberg, G., Stoffel, L., Kohler, T., Klein, S.D., Eschenmoser, M., Mitter, V.R., Nelle, M. and Wolf, U (2020) 'Euphrasia eye drops in preterm neonates with ocular discharge: a randomized double-blind placebo-controlled trial', Frontiers in Pediatrics, 8, pp. 449. doi:10.3389/fped.2020.00449 Randomized trial
https://doi.org/10.3389/fped.2020.00449 - Liu, Y., Hwang, E., Ngo, H.T.T., Perumalsamy, H., Kim, Y.J., Li, L. and Yi, T.H (2018) 'Protective effects of Euphrasia officinalis extract against ultraviolet B-induced photoaging in normal human dermal fibroblasts', International Journal of Molecular Sciences, 19(11), pp. 3327. doi:10.3390/ijms19113327 Preclinical
https://doi.org/10.3390/ijms19113327 - Porchezhian, E., Ansari, S.H. and Shreedharan, N.K (2000) 'Antihyperglycemic activity of Euphrasia officinale leaves', Fitoterapia, 71(5), pp. 522-526. doi:10.1016/s0367-326x(00)00204-5 Preclinical
https://doi.org/10.1016/s0367-326x(00)00204-5 - Sticher, O. and Salama, O (1981) 'Iridoid glucosides from Euphrasia rostkoviana', Planta Medica, 42(6), pp. 122-123. doi:10.1055/s-2007-971584 Preclinical
https://doi.org/10.1055/s-2007-971584 - Lorenz, P., Knittel, D.N., Conrad, J., Lotter, E.M., Heilmann, J., Stintzing, F.C. and Kammerer, D.R (2016) '1-Acetyl-3-[(3R)-hydroxyfatty acyl]glycerols: lipid compounds from Euphrasia rostkoviana Hayne and E. tetraquetra (Breb.) Arrond', Chemistry & Biodiversity, 13(5), pp. 602-612. doi:10.1002/cbdv.201500233 Preclinical
https://doi.org/10.1002/cbdv.201500233 - Gawenda-Kempczynska, D., Olech, M., Balcerek, M., Nowak, R., Zaluski, T. and Zaluski, D (2022) 'Phenolic acids as chemotaxonomic markers able to differentiate the Euphrasia species', Phytochemistry, 203, pp. 113342. doi:10.1016/j.phytochem.2022.113342 Preclinical
https://doi.org/10.1016/j.phytochem.2022.113342 - Benedec, D., Oniga, I., Hanganu, D., Vlase, A.M., Ielciu, I., Crisan, G., Fit, N., Niculae, M., Bab, T., Pall, E. and Vlase, L (2024) 'Revealing the Phenolic Composition and the Antioxidant, Antimicrobial and Antiproliferative Activities of Two Euphrasia sp. Extracts', Plants, 13(13), pp. 1790. doi:10.3390/plants13131790 Preclinical
https://doi.org/10.3390/plants13131790 - Herbal Reality (n.d.) 'Eyebright (Euphrasia officinalis): Benefits, Uses, Safety'. Available at: https://www.herbalreality.com/herb/eyebright/ Traditional / reference
https://www.herbalreality.com/herb/eyebright/ - Paduch, R. and colleagues (2014) 'Assessment of Eyebright (Euphrasia officinalis L.) Extract Activity in Relation to Human Corneal Cells Using In Vitro Tests'. doi:10.5152/balkanmedj.2014.8377 Traditional / reference
https://doi.org/10.5152/balkanmedj.2014.8377 - Stoss, M., Michels, C., Peter, E., Beutke, R. and Gorter, R.W (2000) 'Prospective cohort trial of Euphrasia single-dose eye drops in conjunctivitis', Journal of Alternative and Complementary Medicine, 6(6), pp. 499--508. doi:10.1089/acm.2000.6.499 Clinical study
https://doi.org/10.1089/acm.2000.6.499 - European Medicines Agency (HMPC) (2010) 'Public statement on Euphrasia officinalis L. and Euphrasia rostkoviana Hayne, herba'. Available at: https://www.ema.europa.eu/en/documents/herbal-report/final-public-statement-euphrasia-officinalis-l-and-euphrasia-rostkoviana-hayne-herba_en.pdf Traditional / reference
https://www.ema.europa.eu/en/documents/herbal-report/final-public-statement-euphrasia-officinalis-l-and-euphrasia-rostkoviana-hayne-herba_en.pdf
Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.